Treating irritable bowel syndrome: overview, perspective and future therapies

被引:44
作者
Camilleri, M [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Coll Med, CENTER Program, Rochester, MN 55905 USA
关键词
colonic diseases; functional; treatment; challenges; opportunities;
D O I
10.1038/sj.bjp.0705741
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This article summarizes the ongoing challenges in irritable bowel syndrome and the exciting opportunities for development of novel therapies for this common, enigmatic condition. The challenges include insufficient understanding of mechanisms, lack of specificity of symptoms, differentiation from other conditions, and lack of availability of noninvasive tests to identify dysfunctions. However, significant opportunities are reflected by the advances in clinical trial design and, particularly, clinically relevant end points for such trials, and the increasing understanding of basic neuroenteric science. The latter has delivered two new medications to the practice (alosetron and tegaserod), and other candidate therapies (other serotonergic, tachykininergic, opioid, cannabinoid modulators) are being carefully appraised as potential drugs for the future.
引用
收藏
页码:1237 / 1248
页数:12
相关论文
共 121 条
[1]  
ARGENYI EE, 1995, AM J GASTROENTEROL, V90, P938
[2]   SEGMENTAL COLONIC TRANSIT-TIME [J].
ARHAN, P ;
DEVROEDE, G ;
JEHANNIN, B ;
LANZA, M ;
FAVERDIN, C ;
DORNIC, C ;
PERSOZ, B ;
TETREAULT, L ;
PEREY, B ;
PELLERIN, D .
DISEASES OF THE COLON & RECTUM, 1981, 24 (08) :625-629
[3]   Abdominal distension after colonic lactulose fermentation recorded by a new extensometer [J].
Basilisco, G ;
Marino, B ;
Passerini, L ;
Ogliari, C .
NEUROGASTROENTEROLOGY AND MOTILITY, 2003, 15 (04) :427-433
[4]   Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist Alosetron [J].
Berman, SM ;
Chang, L ;
Suyenobu, B ;
Derbyshire, SW ;
Stains, J ;
Fitzgerald, L ;
Mandelkern, M ;
Hamm, L ;
Vogt, B ;
Naliboff, BD ;
Mayer, EA .
GASTROENTEROLOGY, 2002, 123 (04) :969-977
[5]   Adrenergic modulation of human colonic motor and sensory function [J].
Bharucha, AE ;
Camilleri, M ;
Zinsmeister, AR ;
Hanson, RB .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1997, 273 (05) :G997-G1006
[6]   5-HT2B receptors play a key role in mediating the excitatory effects of 5-HT in human colon in vitro [J].
Borman, RA ;
Tilford, NS ;
Harmer, DW ;
Day, N ;
Ellis, ES ;
Sheldrick, RLG ;
Carey, J ;
Coleman, RA ;
Baxter, GS .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (05) :1144-1151
[7]   Rectal distention testing in patients with irritable bowel syndrome:: Sensitivity, specificity, and predictive values of pain sensory thresholds [J].
Bouin, M ;
Plourde, V ;
Boivin, M ;
Riberdy, M ;
Lupien, F ;
Laganière, M ;
Verrier, P ;
Poitras, P .
GASTROENTEROLOGY, 2002, 122 (07) :1771-1777
[8]   SPECT imaging of the stomach: comparison with barostat, and effects of sex, age, body mass index, and fundoplication [J].
Bouras, EP ;
Delgado-Aros, S ;
Camilleri, M ;
Castillo, EJ ;
Burton, DD ;
Thomforde, GM ;
Chial, HJ .
GUT, 2002, 51 (06) :781-786
[9]   Management of the irritable bowel syndrome [J].
Camilleri, M .
GASTROENTEROLOGY, 2001, 120 (03) :652-668
[10]   Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial [J].
Camilleri, M ;
Northcutt, AR ;
Kong, S ;
Dukes, GE ;
McSorley, D ;
Mangel, AW .
LANCET, 2000, 355 (9209) :1035-1040